NEW YORK, March 30 (GenomeWeb News) - Orchid Cellmark will delay the filing of its fourth-quarter and full-year 2005 earnings reports with the US Securities and Exchange commission due to audit requirements associated with the Sarbanes-Oxley Act of 2002.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.